Detalhe da pesquisa
1.
Clinical, biological, and prognostic implications of SF3B1 co-occurrence mutations in very low/low- and intermediate-risk MDS patients.
Ann Hematol
; 100(8): 1995-2004, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33409621
2.
Phase 1 study of JNJ-64619178, a protein arginine methyltransferase 5 inhibitor, in patients with lower-risk myelodysplastic syndromes.
Leuk Res
; 134: 107390, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37776843